05. Health Contribution Study

Maximising our health contribution requires top-class insights.


No one knows more than we do about the benefits of oral nicotine – and the positive effects it can have on global tobacco-related illnesses and death. As snus contains nicotine, it can act as a substitute for cigarettes – and it is a lot less harmful to your health than smoking. Snus is often used by smokers as a means to quit smoking and some people choose to start using snus instead of starting to smoke. For these reasons, snus can be seen as a consumer product that helps reduce the negative effects of smoking. With these factors in mind, Haypp Group wants to assess how snus and similar nicotine products can help to reduce the damage from smoking.


We address a number of difficult questions:

  • How many positive health differences can be attributed to snus?
  • How has snus and different conditions contributed to health effects in Sweden and Norway – the two countries where snus is most common?
  • Has the ban on snus in the EU contributed to deteriorating public health?
  • How could public health in the EU be improved if snus were permitted?
  • Exploring different ways of thinking about the health effects – and how we can measure them.

The purpose is to see how  snus contributes to reducing smoke-related damage. For an accurate result, different calculations should be performed, with different assumptions, and based on different starting points.

An important part of this work is to ensure that calculation methods are simple and transparent. Ensuring that as many people as possible understand the assumptions on which they are based, thus alleviating uncertainty.